急性住院期间和之后的阿片类药物使用障碍管理:以病例为基础的回顾:明确急症护理环境中的美沙酮管理。

Amanda Noska, Aron Mohan, Sarah Wakeman, Josiah Rich, Amy Boutwell
{"title":"急性住院期间和之后的阿片类药物使用障碍管理:以病例为基础的回顾:明确急症护理环境中的美沙酮管理。","authors":"Amanda Noska, Aron Mohan, Sarah Wakeman, Josiah Rich, Amy Boutwell","doi":"10.4172/2324-9005.1000138","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Treatment with an opioid agonist such as methadone or buprenorphine is the standard of care for opioid use disorder. Persons with opioid use disorder are frequently hospitalized, and may be undertreated due to provider misinformation regarding the legality of prescribing methadone for inpatients. Using a case-based review, this article aims to describe effective management of active opioid withdrawal and ongoing opioid use disorder using methadone or buprenorphine among acutely ill, hospitalized patients.</p><p><strong>Methods: </strong>We reviewed pertinent medical and legal literature and consulted with national legal experts regarding methadone for opioid withdrawal and opioid maintenance therapy in hospitalized, general medical and surgical patients, and describe a real-life example of successful implementation of inpatient methadone for these purposes.</p><p><strong>Results: </strong>Patients with opioid use disorders can be effectively and legally initiated on methadone maintenance therapy or buprenorphine during an inpatient hospitalization by clinical providers and successfully transitioned to an outpatient methadone maintenance or buprenorphine clinic after discharge for ongoing treatment.</p><p><strong>Conclusions: </strong>Inpatient methadone or buprenorphine prescribing is safe and evidence-based, and can be used to effectively treat opioid withdrawal and also serves as a bridge to outpatient treatment of opioid use disorders.</p>","PeriodicalId":90201,"journal":{"name":"Journal of addictive behaviors, therapy & rehabilitation","volume":"4 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527170/pdf/nihms701820.pdf","citationCount":"0","resultStr":"{\"title\":\"Managing Opioid Use Disorder During and After Acute Hospitalization: A Case-Based Review Clarifying Methadone Regulation for Acute Care Settings.\",\"authors\":\"Amanda Noska, Aron Mohan, Sarah Wakeman, Josiah Rich, Amy Boutwell\",\"doi\":\"10.4172/2324-9005.1000138\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Treatment with an opioid agonist such as methadone or buprenorphine is the standard of care for opioid use disorder. Persons with opioid use disorder are frequently hospitalized, and may be undertreated due to provider misinformation regarding the legality of prescribing methadone for inpatients. Using a case-based review, this article aims to describe effective management of active opioid withdrawal and ongoing opioid use disorder using methadone or buprenorphine among acutely ill, hospitalized patients.</p><p><strong>Methods: </strong>We reviewed pertinent medical and legal literature and consulted with national legal experts regarding methadone for opioid withdrawal and opioid maintenance therapy in hospitalized, general medical and surgical patients, and describe a real-life example of successful implementation of inpatient methadone for these purposes.</p><p><strong>Results: </strong>Patients with opioid use disorders can be effectively and legally initiated on methadone maintenance therapy or buprenorphine during an inpatient hospitalization by clinical providers and successfully transitioned to an outpatient methadone maintenance or buprenorphine clinic after discharge for ongoing treatment.</p><p><strong>Conclusions: </strong>Inpatient methadone or buprenorphine prescribing is safe and evidence-based, and can be used to effectively treat opioid withdrawal and also serves as a bridge to outpatient treatment of opioid use disorders.</p>\",\"PeriodicalId\":90201,\"journal\":{\"name\":\"Journal of addictive behaviors, therapy & rehabilitation\",\"volume\":\"4 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527170/pdf/nihms701820.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of addictive behaviors, therapy & rehabilitation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4172/2324-9005.1000138\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of addictive behaviors, therapy & rehabilitation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2324-9005.1000138","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的:美沙酮或丁丙诺啡等阿片类药物激动剂治疗是阿片类药物使用障碍的标准治疗方法。阿片类药物使用障碍患者经常住院治疗,由于提供者在为住院患者开具美沙酮处方的合法性方面存在误导,可能导致治疗不足。本文以病例为基础,旨在描述使用美沙酮或丁丙诺啡治疗急性住院患者阿片类药物主动戒断和持续阿片类药物使用障碍的有效方法:我们查阅了相关的医学和法律文献,并就美沙酮用于住院普通内科和外科病人的阿片类药物戒断和阿片类药物维持治疗咨询了国内法律专家,并描述了一个成功实施住院美沙酮用于上述目的的真实案例:结果:阿片类药物使用障碍患者可以在住院期间由临床医疗人员有效、合法地开始美沙酮维持治疗或丁丙诺啡治疗,并在出院后成功过渡到美沙酮维持治疗或丁丙诺啡门诊进行持续治疗:住院患者美沙酮或丁丙诺啡的处方是安全和以证据为基础的,可用于有效治疗阿片类药物戒断,也可作为阿片类药物使用障碍门诊治疗的桥梁。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Managing Opioid Use Disorder During and After Acute Hospitalization: A Case-Based Review Clarifying Methadone Regulation for Acute Care Settings.

Objective: Treatment with an opioid agonist such as methadone or buprenorphine is the standard of care for opioid use disorder. Persons with opioid use disorder are frequently hospitalized, and may be undertreated due to provider misinformation regarding the legality of prescribing methadone for inpatients. Using a case-based review, this article aims to describe effective management of active opioid withdrawal and ongoing opioid use disorder using methadone or buprenorphine among acutely ill, hospitalized patients.

Methods: We reviewed pertinent medical and legal literature and consulted with national legal experts regarding methadone for opioid withdrawal and opioid maintenance therapy in hospitalized, general medical and surgical patients, and describe a real-life example of successful implementation of inpatient methadone for these purposes.

Results: Patients with opioid use disorders can be effectively and legally initiated on methadone maintenance therapy or buprenorphine during an inpatient hospitalization by clinical providers and successfully transitioned to an outpatient methadone maintenance or buprenorphine clinic after discharge for ongoing treatment.

Conclusions: Inpatient methadone or buprenorphine prescribing is safe and evidence-based, and can be used to effectively treat opioid withdrawal and also serves as a bridge to outpatient treatment of opioid use disorders.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信